Mangalam Drugs and Organics reports consolidated net loss of Rs 13.80 crore in the June 2025 quarter
Sales decline 25.21% to Rs 57.21 crore
Net loss of Mangalam Drugs and Organics reported to Rs 13.80 crore in the quarter ended June 2025 as against net profit of Rs 2.68 crore during the previous quarter ended June 2024. Sales declined 25.21% to Rs 57.21 crore in the quarter ended June 2025 as against Rs 76.49 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales57.2176.49 -25 OPM %-7.8310.71 -PBDT-8.524.46 PL PBT-13.000.58 PL NP-13.802.68 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content